Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
21.23
+0.95 (4.68%)
May 7, 2025, 4:00 PM EDT - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $343.88 million as of May 7, 2025. Its market cap has decreased by -5.20% in one year.
Market Cap
343.88M
Enterprise Value
4.87B
1-Year Change
-5.20%
Ranking
Category
Stock Price
$21.23
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $343.88M, an increase of 41.52%. That is a compound annual growth rate of 7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 343.88M | 43.88% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 354.75B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |